RXRX Operating Cash Flow (Statement)
Recursion Pharmaceuticals Inc Clas · Operating Cash Flow (Statement)
RXRX Operating Cash Flow (Statement)
Latest reported-$105.95Mperiod ending
RXRX Quarterly Cash from Operations (-$17.82M → -$105.95M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
RXRX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -105,947,000 | |
| -81,101,000 | |
| -46,073,000 | |
| -117,360,000 | |
| -76,418,000 | |
| -131,957,000 | |
| -115,430,000 | |
| -59,225,000 | |
| -82,219,000 | |
| -102,300,000 | |
| -74,077,000 | |
| -72,920,000 | |
| -67,467,000 | |
| -73,316,000 | |
| -44,748,000 | |
| -54,541,000 | |
| -61,623,000 | |
| 77,388,000 | |
| -61,158,000 | |
| -33,048,000 | |
| -33,653,000 | |
| -30,755,000 | |
| 8,573,000 | |
| -19,456,000 | |
| -16,699,000 | |
| -17,817,000 |